Acinetobacter baumanii
Multiresistance per hospital
(resistance to ceftazidime, ciprofloxacin and amikacin)
All clinical specimens
(July - December 2011)

Hospital
Medical Wards
Surgical Wards
ICU
%aba/total isolates
Isolates Tested
%R
%aba/total isolates
Isolates Tested
%R
%aba/total isolates
Isolates Tested
%R
GR001
3,20%
3
 
1,00%
1
 
 
 
 
GR005
1,90%
6
 
2,33%
7
85,7
17,19%
55
92,7
GR007
 
 
 
3,53%
3
 
5,23%
19
84,2
GR011*
1,14%
15
0,0
 
 
 
2,55%
4
 
GR014
5,16%
23
0,0
2,29%
2
 
20,12%
5
 
GR015
2,20%
6
 
3,54%
4
 
11,58%
21
95,2
GR018
4,58%
8
0,0
4,03%
3
 
21,86%
2
 
GR026
0,33%
1
 
1,80%
6
 
23,53%
18
88,9
GR027
3,46%
29
48,3
3,22%
11
9,1
19,03%
71
50,7
GR028
 
 
 
 
 
 
2,04%
1
 
GR030
8,93%
59
79,7
18,40%
128
82,8
20,20%
118
60,2
GR031
2,34%
22
72,7
5,71%
48
89,6
35,37%
152
82,9
GR033
2,69%
14
92,9
4,24%
13
53,8
18,05%
71
97,2
GR035
4,12%
35
77,1
4,30%
12
66,7
20,67%
30
93,3
GR037
3,87%
26
73,1
11,72%
23
60,9
19,71%
127
72,4
GR039
 
 
 
8,53%
2
 
20,86%
3
 
GR040
3,81%
51
60,8
6,07%
51
76,5
14,27%
121
79,3
GR043
2,80%
23
91,3
 
 
 
21,05%
77
81,8
GR046*
1,92%
2
 
 
 
 
3,33%
1
 
GR047
2,07%
26
92,3
3,14%
25
96,0
21,64%
29
100,0
GR048
2,53%
7
71,4
3,09%
8
87,5
 
 
 
GR049
 
 
 
0,88%
1
 
1,25%
1
 
GR050
3,98%
34
55,9
1,66%
7
28,6
19,73%
37
56,8
GR052
0,62%
1
 
0,78%
1
 
 
 
 
GR062
1,51%
7
57,1
1,31%
3
 
22,81%
26
84,6
GR068
4,71%
13
69,2
6,60%
58
63,8
22,12%
47
87,2
GR075
2,15%
16
56,3
5,51%
19
52,6
15,10%
61
78,7
 
 
 
 
 
 
 
 
 
 
Weighted Average
3,37%
427
63,5
5,42%
436
71,6
18,76%
1097
77,6
 
 
 
 
 
 
 
 
 
 
Hospital Mean
 
 
58,7
 
 
65,7
 
 
81,5
* Children's Hospital

Back